Institutional investors hold a majority ownership of OREX through the 77.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $1.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LIFESCI INDEX PARTNERS LLC Bought 24.5 Thousand shares of Orexigen Therapeutics Inc